Cancer and pediatric inflammatory bowel disease

Loftus, 2004, Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences, Gastroenterology, 126, 1504, 10.1053/j.gastro.2004.01.063 Farrokhyar, 2001, A critical review of epidemiological studies in inflammatory bowel disease, Scand J Gastroenterol, 36, 2, 10.1080/00365520150218002 Barton, 1989, Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983; marginal fall in ulcerative colitis, three-fold rise in Crohn’s disease, Gut, 30, 618, 10.1136/gut.30.5.618 Sivarajasingham, 2003, Perianal Hodgkin’s lymphoma complicating Crohn’s disease, Int J Colorectal Dis, 18, 174, 10.1007/s00384-002-0448-x Hill, 2002, Perianal rhabdomyosarcoma presenting as a perirectal abscess: a report of 11 cases, J Pediatr Surg, 37, 576, 10.1053/jpsu.2002.31613 Oberto, 2004, Malignant peritoneal mesothelioma in a pediatric patient mimicking inflammatory bowel disease, Dig Dis Sci, 49, 434, 10.1023/B:DDAS.0000020498.50909.54 Merino, 1979, Small cell malignant tumors of childhood: clinically presenting as inflammatory bowel disease, Conn Med, 43, 621 Maaravi, 1993, A unique presentation of lymphoma of the colon, J Clin Gastroenterol, 17, 49, 10.1097/00004836-199307000-00014 McCullough, 1992, Mantle zone lymphoma of the colon simulating diffuse inflammatory bowel disease, Dig Dis Sci, 37, 934, 10.1007/BF01300394 Kapoor, 1996, Diffuse large cell lymphoma presenting as inflammatory bowel disease in an adolescent with ataxia telangiectasia, Leuk Res, 20, 997, 10.1016/S0145-2126(96)00033-1 Codling, 1977, Hodgkin’s disease complicating Crohn’s colitis, Surgery, 82, 625 Vanbockrijck, 1993, Primary Hodgkin disease of the ileum complicating Crohn disease, Cancer, 72, 1784, 10.1002/1097-0142(19930901)72:5<1784::AID-CNCR2820720544>3.0.CO;2-X Vincenzi, 2001, Unusual presentation of Hodgkin’s disease mimicking inflammatory bowel disease, Leuk Lymphoma, 42, 521, 10.3109/10428190109064611 Nordenholtz, 1995, The cause of death in inflammatory bowel disease: a comparison of death certificates and hospital charts in Rochester, New York, Am J Gastroenterol, 90, 927 Ekbom, 1992, Survival and causes of death in patients with inflammatory bowel disease: a population-based study, Gastroenterol, 103, 954, 10.1016/0016-5085(92)90029-X Persson, 1996, Survival and cause-specific mortality in inflammatory bowel disease: a population-based study, Gastroenterol, 110, 1339, 10.1053/gast.1996.v110.pm8613037 Jess, 2006, Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004, Gut, 55, 1248, 10.1136/gut.2005.079350 Jess, 2006, Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota, Gastroenterology, 130, 1039, 10.1053/j.gastro.2005.12.037 Bernstein, 2001, Cancer risk in patients with inflammatory bowel disease: a population-based study, Cancer, 91, 854, 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z Tiszlavicz, 2000, Adenocarcinoma of the colon developing on the basis of Crohn’s disease in childhood, Eur J Pediatr, 160, 168, 10.1007/s004310000699 Michener, 1961, The prognosis of chronic ulcerative colitis in children, N Engl J Med, 265, 1075, 10.1056/NEJM196111302652201 Eaden, 2001, The risk of colorectal cancer in ulcerative colitis: a meta-analysis, Gut, 48, 526, 10.1136/gut.48.4.526 Gillen, 1994, Crohn’s disease and colorectal cancer, Gut, 35, 651, 10.1136/gut.35.5.651 Askling, 2001, Family history as a risk factor for colorectal cancer in inflammatory bowel disease, Gastroenterology, 120, 1356, 10.1053/gast.2001.24052 Ekbom, 1990, Ulcerative colitis and colorectal cancer: a population-based study, N Engl J Med, 323, 1228, 10.1056/NEJM199011013231802 Ekbom, 1990, Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement, Lancet, 336, 357, 10.1016/0140-6736(90)91889-I Gumaste, 1992, Benign and malignant colorectal strictures in ulcerative colitis, Gut, 33, 938, 10.1136/gut.33.7.938 Stahl, 1992, Crohn’s disease and carcinoma: increasing justification for surveillance?, Dis Colon Rectum, 35, 850, 10.1007/BF02047872 Heuschen, 2001, Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis, Gastroenterology, 120, 841, 10.1053/gast.2001.22434 Broomé, 1995, Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential, Hepatology, 22, 1404 Marchesa, 1997, The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis, Am J Gastroenterol, 92, 1285 Shetty, 1999, The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis, Am J Gastroenterol, 94, 1643, 10.1111/j.1572-0241.1999.01156.x Knechtle, 1995, Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation, Surgery, 118, 615, 10.1016/S0039-6060(05)80026-1 Loftus, 1998, Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation, Hepatology, 27, 685, 10.1002/hep.510270308 Vera, 2003, Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis, Transplantation, 75, 1983, 10.1097/01.TP.0000058744.34965.38 Siegel, 2006, Risk factors for colorectal cancer in Crohn’s colitis: a case-control study, Inflamm Bowel Dis, 12, 491, 10.1097/00054725-200606000-00008 Choi, 1993, Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis, Gastroenterology, 105, 418, 10.1016/0016-5085(93)90715-O Collins, 2006, Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease, Cochrane Database Syst Rev, 2, 10.1002/14651858.CD000279.pub3 Eaden, 2002, Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease, Gut, 51, v10, 10.1136/gut.51.suppl_5.v10 Bernstein, 1994, Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?, Lancet, 343, 71, 10.1016/S0140-6736(94)90813-3 Itzkowitz, 2002, Cancer prevention in patients with inflammatory bowel disease, Gastroenterol Clin North Am, 31, 1133, 10.1016/S0889-8553(02)00047-X Sarigol, 1999, Incidence of dysplasia in pelvic pouches in pediatric patients after ileal pouch-anal anastomosis for ulcerative colitis, J Pediatr Gastroenterol Nutr, 28, 429, 10.1097/00005176-199904000-00015 Remzi, 2003, Dysplasia of the anal transition zone after ileal pouch-anal anastomosis, Dis Colon Rectum, 46, 6, 10.1007/s10350-004-6488-2 Ejderhamn, 1991, Faecal bile acid excretion in children with inflammatory bowel diseaes, Gut, 32, 1346, 10.1136/gut.32.11.1346 Tung, 2001, Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis, Ann Intern Med, 134, 89, 10.7326/0003-4819-134-2-200101160-00008 Pardi, 2003, Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis, Gastroenterology, 124, 889, 10.1053/gast.2003.50156 Sjöqvist, 2004, Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study, Anticancer Res, 24, 3121 Reinacher-Schick, 2003, Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells, Carcinogenesis, 24, 443, 10.1093/carcin/24.3.443 Eaden, 2000, Colorectal cancer prevention in ulcerative colitis: a case-control study, Aliment Pharmacol Ther, 14, 145, 10.1046/j.1365-2036.2000.00698.x van Staa, 2005, 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study, Gut, 54, 1573, 10.1136/gut.2005.070896 Bernstein, 2003, Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?, Am J Gastroenterol, 98, 2784, 10.1111/j.1572-0241.2003.08718.x Terdiman, 2007, 5-Aminosalicylic acid therapy and the risk of colrectal cancer among patients with inflammatory bowel disease, Inflamm Bowel Dis, 13, 1, 10.1002/ibd.20074 Freudenheim, 1991, Folate intake and carcinogenesis of the colon and rectum, Int J Epidemiol, 20, 368, 10.1093/ije/20.2.368 Persson, 1994, Crohn’s disease and cancer: a population-based cohort study, Gastroenterol, 107, 1675, 10.1016/0016-5085(94)90807-9 Munkhold, 1993, Intestinal cancer risk and mortality in patients with Crohn’s disease, Gastroenterology, 105, 1716, 10.1016/0016-5085(93)91068-S Lashner, 1992, Risk factors for small bowel cancer in Crohn’s disease, Dig Dis Sci, 37, 1179, 10.1007/BF01296557 Henderson, 1985, Paget’s disease with benign osteopetrosis and Crohn’s disease, J R Soc Med, 78, 766, 10.1177/014107688507800913 Cameron, 1989, Neurofibromatosis and inflammatory bowel disease, Scott Med J, 34, 500, 10.1177/003693308903400407 Pfeffel, 1999, Coincidence of Crohn’s disease and a high-risk gastrointestinal stromal tumor of the terminal ileum, Digestion, 60, 363, 10.1159/000007684 Mijandrušic Sinèic, 2005, Crohn’s disease and a gastrointestinal stromal tumor in an 81-year-old man: a rare coincidence, Zentralbl Chir, 130, 597, 10.1055/s-2005-918206 Laukhuf, 2002, Crohn’s disease and stromal sarcoma of the small bowel: a rare coincidence, Z Gastroenterol, 40, 193, 10.1055/s-2002-22320 Papadopoulos, 2003, Coexistence of inflammatory bowel disease and gastrointestinal stromal tumor: a case report, Int J Intern Med, 4, 7 Listinsky, 1994, Ultrastructural and immunocytochemical features of a case of neuroendocrine carcinoma developing in a prior ileostomy site, Ultrastruct Pathol, 18, 503, 10.3109/01913129409023226 Le Marc’hadour, 1994, Carcinoid tumour complicating inflammatory bowel disease, Pathol Res Pract, 190, 1185, 10.1016/S0344-0338(11)80445-0 Greenstein, 1997, Carcinoid tumor and inflammatory bowel disease: a study of eleven cases and review of the literature, Am J Gastroenterol, 92, 682 Sigel, 1998, Neuroendocrine neoplasms arising in inflammatory bowel disease: a report of 14 cases, Mod Pathol, 11, 537 Israel, 1986, Association of inflammatory bowel disease (IBD) with indolent soft-tissue sarcomas: report of two cases and review of literature, J Surg Oncol, 32, 125, 10.1002/jso.2930320217 DiGiacomo, 1994, Mesenteric fibromatosis associated with Crohn’s disease, Am J Gastroenterol, 89, 1103 Slater, 1996, Mesenteric fibromatosis in Crohn’s disease, J Clin Gastroenterol, 22, 147, 10.1097/00004836-199603000-00017 Greenstein, 1992, Malignant melanoma in inflammatory bowel disease, Am J Gastroenterol, 87, 317 Slater, 1984, Anal carcinoma in patients with Crohn’s disease, Ann Surg, 199, 348, 10.1097/00000658-198403000-00016 Kulaylat, 1995, Squamous cell carcinoma complicating idiopathic inflammatory bowel disease, J Surg Oncol, 59, 48, 10.1002/jso.2930590113 Frisch, 2000, Anal carcinoma in inflammatory bowel disease, Br J Cancer, 83, 89, 10.1054/bjoc.2000.1153 Greenstein, 1985, Extraintestinal cancers in inflammatory bowel disease, Cancer, 56, 2914, 10.1002/1097-0142(19851215)56:12<2914::AID-CNCR2820561232>3.0.CO;2-J Ekbom, 1991, Extracolonic malignancies in inflammatory bowel disease, Cancer, 67, 2015, 10.1002/1097-0142(19910401)67:7<2015::AID-CNCR2820670731>3.0.CO;2-R Thompson, 1989, Kaposi’s sarcoma of the colon in a young HIV-negative man with chronic ulcerative colitis, Dis Colon Rectum, 32, 73, 10.1007/BF02554731 Puy-Montbrun, 1991, Kaposi’s sarcoma of the colon in a young HIV-negative woman with Crohn’s disease, Dig Dis Sci, 36, 528, 10.1007/BF01298888 Koop, 1987, Fulminant Kaposi’s sarcoma complicating long-term corticosteroid therapy, Am J Med, 83, 787, 10.1016/0002-9343(87)90916-8 Tedesco, 1999, Colorectal Kaposi’s sarcoma in an HIV-negative male in association with ulcerative rectocolitis: a case report, Anticanc Res, 19, 3045 Cohen, 2001, Kaposi’s sarcoma and cytomegaloviral ileocolitis complicating long-standing Crohn’s disease in an HIV-negative patient, Am J Gastroenterol, 96, 3028, 10.1111/j.1572-0241.2001.04676.x Bursics, 2005, HHV-8 positive, HIV negative disseminated Kaposi’s sarcoma complicating steroid dependent ulcerative colitis: a successfully treated case, Gut, 54, 1049, 10.1136/gut.2005.069500 Meltzer, 1987, Kaposi’s sarcoma occurring in association with ulcerative colitis, Am J Gastroenterol, 82, 378 Adlersberg, 1970, Kaposi’s sarcoma complicating ulcerative colitis: report of a case, Am J Clin Pathol, 54, 143, 10.1093/ajcp/54.1.143 Gordon, 1966, Kaposi’s sarcoma of the large intestine associated with ulcerative colitis, Gastroenterology, 50, 248, 10.1016/S0016-5085(66)80058-6 Mackey, 2007, Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease, J Pediatr Gastroenterol Nutr, 44, 265, 10.1097/MPG.0b013e31802f6424 Ljung, 2004, Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County, Gut, 53, 849, 10.1136/gut.2003.018515 Sandborn, 2004, Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease, Gut, 53, 780, 10.1136/gut.2003.020552 Lewis, 2001, Inflammatory bowel disease is not associated with an increased risk of lymphoma, Gastroenterology, 121, 1080, 10.1053/gast.2001.28703 Loftus, 2000, Risk of lymphoma in inflammatory bowel disease, Am J Gastroenterol, 95, 2308, 10.1111/j.1572-0241.2000.02316.x Askling, 2005, Risk of haematopoietic cancer in patients with inflammatory bowel disease, Gut, 54, 617, 10.1136/gut.2004.051771 Kandiel, 2005, Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine, Gut, 54, 1121, 10.1136/gut.2004.049460 Sonwalkar, 2003, Fulminant Crohn’s colitis after allogeneic stem cell transplantation, Gut, 52, 1518, 10.1136/gut.52.10.1518 Sklar, 2001, Endocrine complications of pediatric stem cell transplantation, Front Biosci, 6, g17, 10.2741/A714 Ditschkowski, 2003, Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation, Transplantation, 75, 1745, 10.1097/01.TP.0000062540.29757.E9 Oyama, 2005, Autologous hematopoietic stem cell transplantation in patients with refractory Crohn’s disease, Gastroenterology, 128, 552, 10.1053/j.gastro.2004.11.051 Itzkowitz, 2005, Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease, Inflamm Bowel Dis, 11, 314, 10.1097/01.MIB.0000160811.76729.d5